| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Oncology and Molecular Endocrinology, Research Center, Medical Research Council Group in Molecular Endocrinology (A.B.), CHUL Research Center, Laval University, Québec, Canada G1V 4G2
Address all correspondence and requests for reprints to: Dr. Dean W. Hum or Dr. Alain Bélanger, Oncology and Molecular Endocrinology Research Center, CHUL Research Center, 2705 Laurier boulevard, Québec, Canada G1V 4G2. E-mail: dean.hum@crchul.ulaval.ca and alain.belanger{at}crchul.ulaval.ca
Based on the similarity of pathways and enzymes involved in steroid
metabolism, simians represent a relevant animal model to study steroid
elimination by glucuronidation. In this study the tissue distribution
of UDP-glucuronosyltransferase (UGT) transcripts, proteins, and
enzymatic activities were examined in 24 different cynomolgus monkey
tissues. RT-PCR and Western blot analysis on total RNA and microsomal
proteins demonstrated the presence of UGT1A and UGT2B transcripts and
proteins in a wide range of tissues including steroid target tissues.
Glucuronidation activity on eugenol, 5
-androstane-3
,17ß-diol,
androsterone, and 4-hydroxyestradiol was measured using tissue
homogenates and radiolabeled [14C]UDP-glucuronic acid.
All tissues contained conjugation activity on these substrates, but
glucuronidation rates were significantly lower in steroid target
tissues than in liver, kidney, or gut. However, the ratio of steroid
glucuronidation vs. eugenol glucuronidation was higher
in steroid target tissues, suggesting a differential expression of
steroid-conjugating enzymes in these tissues. Taken together, these
results clearly demonstrate the presence of steroid glucuronidation
enzymes in extrahepatic steroid target tissues and support the
hypothesis that steroid glucuronidation is an important intracrine
pathway involved in termination of steroid signaling.
This article has been cited by other articles:
![]() |
J. Balthazart, M. Baillien, and G. F. Ball Rapid Control of Brain Aromatase Activity by Glutamatergic Inputs Endocrinology, January 1, 2006; 147(1): 359 - 366. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Leblanc, M.-C. Belanger, P. Julien, A. Tchernof, C. Labrie, A. Belanger, and F. Labrie Plasma Lipoprotein Profile in the Male Cynomolgus Monkey under Normal, Hypogonadal, and Combined Androgen Blockade Conditions J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1849 - 1857. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Leblanc, C. Labrie, A. Belanger, B. Candas, and F. Labrie Bioavailability and Pharmacokinetics of Dehydroepiandrosterone in the Cynomolgus Monkey J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4293 - 4302. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Barbier, C. Girard, L. Berger, M. El Alfy, A. Belanger, and D. W. Hum The Androgen-Conjugating Uridine Diphosphoglucuronosyltransferase-2B Enzymes Are Differentially Expressed Temporally and Spatially in the Monkey Follicle throughout the Menstrual Cycle Endocrinology, June 1, 2001; 142(6): 2499 - 2507. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Barbier, C. Albert, I. Martineau, M. Vallée, K. High, F. Labrie, D. W. Hum, C. Labrie, and A. Bélanger Glucuronidation of the Nonsteroidal Antiestrogen EM-652 (SCH 57068), by Human and Monkey Steroid Conjugating UDP-Glucuronosyltransferase Enzymes Mol. Pharmacol., March 1, 2001; 59(3): 636 - 645. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |